Pain Patients Speak In Favor of Direct-to-Consumer Promotion by Pharma of Off-Label Use of Drugs Off-Label DTC SurveyIn this 3-minute audio snippet, several anonymous pain patients and advocates tell why they are in favor of allowing pharmaceutical companies to promote or advertise off-label uses of drugs directly to patients.

These patients were interviewed via the inVibe platform, which engages research participants on their smartphones and collects responses via automated, voice-response surveys. Learn more at

The survey was done in preparation for FDA’s Part 15 public hearing on “Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products” on 9-10 November, 2016 (see below). Pharma Marketing News is also hosting a survey of readers on this topic (click survey box above or click here).

Your browser does not support the audio element. Upgrade your browser to one that does
In a Surprise Move, FDA Will Hold a Public Meeting to Review Off-label Marketing